98 related articles for article (PubMed ID: 16413634)
21. Spinal pretreatment with antisense oligodeoxynucleotides against exon-1, -4, or -8 of mu-opioid receptor clone leads to differential loss of spinal endomorphin-1-and endomorphin-2-induced antinociception in the mouse.
Wu HE; Mizoguchi H; Terashvili M; Leitermann RJ; Hung KC; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 2002 Nov; 303(2):867-73. PubMed ID: 12388674
[TBL] [Abstract][Full Text] [Related]
22. Cellular mechanisms of opioid tolerance: studies in single brain neurons.
Christie MJ; Williams JT; North RA
Mol Pharmacol; 1987 Nov; 32(5):633-8. PubMed ID: 2824980
[TBL] [Abstract][Full Text] [Related]
23. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
[TBL] [Abstract][Full Text] [Related]
24. Mu-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.
Connor M; Schuller A; Pintar JE; Christie MJ
Br J Pharmacol; 1999 Apr; 126(7):1553-8. PubMed ID: 10323586
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2).
Fichna J; do-Rego JC; Chung NN; Lemieux C; Schiller PW; Poels J; Broeck JV; Costentin J; Janecka A
J Med Chem; 2007 Feb; 50(3):512-20. PubMed ID: 17266203
[TBL] [Abstract][Full Text] [Related]
26. Receptors for opioid peptides in the guinea-pig ileum.
Takemori AE; Portoghese PS
J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
[TBL] [Abstract][Full Text] [Related]
27. [(35)S]GTPgammaS binding stimulated by endomorphin-2 and morphiceptin analogs.
Fichna J; do-Rego JC; Kosson P; Schiller PW; Costentin J; Janecka A
Biochem Biophys Res Commun; 2006 Jun; 345(1):162-8. PubMed ID: 16677613
[TBL] [Abstract][Full Text] [Related]
28. Activation of mu-opioid receptors inhibits lordosis behavior in estrogen and progesterone-primed female rats.
Acosta-Martinez M; Etgen AM
Horm Behav; 2002 Feb; 41(1):88-100. PubMed ID: 11863387
[TBL] [Abstract][Full Text] [Related]
29. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
30. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
Liu-Chen LY; Yang HH; Li S; Adams JU
J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
[TBL] [Abstract][Full Text] [Related]
31. Characterization of antinociceptive activity of novel endomorphin-2 and morphiceptin analogs modified in the third position.
Fichna J; do-Rego JC; Kosson P; Costentin J; Janecka A
Biochem Pharmacol; 2005 Jan; 69(1):179-85. PubMed ID: 15588726
[TBL] [Abstract][Full Text] [Related]
32. Acute antinociceptive tolerance and asymmetric cross-tolerance between endomorphin-1 and endomorphin-2 given intracerebroventricularly in the mouse.
Wu HE; Hung KC; Mizoguchi H; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 2001 Dec; 299(3):1120-5. PubMed ID: 11714902
[TBL] [Abstract][Full Text] [Related]
33. Mu opioid receptor-effector coupling and trafficking in dorsal root ganglia neurons.
Walwyn WM; Wei W; Xie CW; Chiu K; Kieffer BL; Evans CJ; Maidment NT
Neuroscience; 2006 Oct; 142(2):493-503. PubMed ID: 16887280
[TBL] [Abstract][Full Text] [Related]
34. Activity of mu- and delta-opioid agonists in vas deferens from mice deficient in MOR gene.
Maldonado R; Severini C; Matthes HW; Kieffer BL; Melchiorri P; Negri L
Br J Pharmacol; 2001 Apr; 132(7):1485-92. PubMed ID: 11264242
[TBL] [Abstract][Full Text] [Related]
35. Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.
Tavani A; Petrillo P; La Regina A; Sbacchi M
J Pharmacol Exp Ther; 1990 Jul; 254(1):91-7. PubMed ID: 2164103
[TBL] [Abstract][Full Text] [Related]
36. Possible involvement of dynorphin A-(1-17) release via mu1-opioid receptors in spinal antinociception by endomorphin-2.
Mizoguchi H; Watanabe H; Hayashi T; Sakurada W; Sawai T; Fujimura T; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2006 Apr; 317(1):362-8. PubMed ID: 16394196
[TBL] [Abstract][Full Text] [Related]
37. Antinociceptive effect and enzymatic degradation of endomorphin-1 in newborn rat spinal cord.
Sugimoto-Watanabe A; Kubota K; Fujibayashi K; Saito K
Jpn J Pharmacol; 1999 Nov; 81(3):264-70. PubMed ID: 10622214
[TBL] [Abstract][Full Text] [Related]
38. Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice.
Burke TF; Woods JH; Lewis JW; Medzihradsky F
J Pharmacol Exp Ther; 1994 Nov; 271(2):715-21. PubMed ID: 7965787
[TBL] [Abstract][Full Text] [Related]
39. Mu-receptor binding in physiological media: comparison with isolated tissue data.
Carroll JA; Miller L; Shaw JS; Downes CP
Neuropeptides; 1984 Dec; 5(1-3):89-92. PubMed ID: 6099521
[TBL] [Abstract][Full Text] [Related]
40. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
Al-Khrasani M; Spetea M; Friedmann T; Riba P; Király K; Schmidhammer H; Furst S
Brain Res Bull; 2007 Oct; 74(5):369-75. PubMed ID: 17845912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
